LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 65 of 497
Next
>>
>
1601 to 1625 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	NVP-TAE684	3.33	uM	LJP6	2	K14	72	hr	1097	1398	3769	0.3709	0.1125
BT-20	NVP-TAE684	3.33	uM	LJP6	3	K14	72	hr	1097	1931	3769	0.5123	0.3120
BT-20	Palbociclib	3.33	uM	LJP6	1	E14	72	hr	1097	1530	3769	0.4059	0.1619
BT-20	Palbociclib	3.33	uM	LJP6	2	E14	72	hr	1097	1595	3769	0.4231	0.1863
BT-20	Palbociclib	3.33	uM	LJP6	3	E14	72	hr	1097	1576	3769	0.4181	0.1792
BT-20	PD0325901	3.33	uM	LJP5	1	C02	72	hr	1097	1886	3769	0.5003	0.2952
BT-20	PD0325901	3.33	uM	LJP5	2	C02	72	hr	1097	2266	3769	0.6011	0.4374
BT-20	PD0325901	3.33	uM	LJP5	3	C02	72	hr	1097	2608	3769	0.6919	0.5653
BT-20	PD0325901	3.33	uM	LJP6	1	E02	72	hr	1097	2324	3769	0.6165	0.4591
BT-20	PD0325901	3.33	uM	LJP6	2	E02	72	hr	1097	2326	3769	0.6171	0.4598
BT-20	PD0325901	3.33	uM	LJP6	3	E02	72	hr	1097	2374	3769	0.6298	0.4778
BT-20	PD173074	3.33	uM	LJP6	1	I08	72	hr	1097	4124	3769	1.0940	1.1326
BT-20	PD173074	3.33	uM	LJP6	2	I08	72	hr	1097	3887	3769	1.0312	1.0440
BT-20	PD173074	3.33	uM	LJP6	3	I08	72	hr	1097	4099	3769	1.0874	1.1233
BT-20	PD184352	3.33	uM	LJP5	1	L08	72	hr	1097	3626	3769	0.9619	0.9463
BT-20	PD184352	3.33	uM	LJP5	2	L08	72	hr	1097	3727	3769	0.9887	0.9841
BT-20	PD184352	3.33	uM	LJP5	3	L08	72	hr	1097	3445	3769	0.9139	0.8786
BT-20	Pelitinib	3.33	uM	LJP5	1	I14	72	hr	1097	2312	3769	0.6133	0.4546
BT-20	Pelitinib	3.33	uM	LJP5	2	I14	72	hr	1097	2161	3769	0.5733	0.3981
BT-20	Pelitinib	3.33	uM	LJP5	3	I14	72	hr	1097	2295	3769	0.6088	0.4482
BT-20	PF431396	3.33	uM	LJP5	1	E08	72	hr	1097	1383	3769	0.3669	0.1069
BT-20	PF431396	3.33	uM	LJP5	2	E08	72	hr	1097	1415	3769	0.3754	0.1189
BT-20	PF431396	3.33	uM	LJP5	3	E08	72	hr	1097	1269	3769	0.3367	0.0643
BT-20	PF477736	3.33	uM	LJP5	1	J20	72	hr	1097	3407	3769	0.9038	0.8643
BT-20	PF477736	3.33	uM	LJP5	2	J20	72	hr	1097	3352	3769	0.8892	0.8438

|<
<<
Previous
Page 65 of 497
Next
>>
>
1601 to 1625 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)